2020年12月28日,Elevar Therapeutics宣布与Inceptua Group达成在欧洲分销和商业化Apealea®(紫杉醇胶束)的独家协议。Apealea已获得欧洲监管机构批准,与卡铂联用治疗首次复发的铂敏感性上皮性卵巢癌、原发性腹膜癌、输卵管癌成人患者。根据协...查看全文
$Oasmia Pharmaceutical AB(OASM)$ CT ORDER - Confidential treatment order Filed: 2015-10-27 AccNo: 9999999997-15-014302 Size: 10 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ CERTNAS [Paper] - Certification by the National Association of Securities Dealers Automated Quotation approving securities for l Film#: 15008146 Filed: 2015-10-22 AccNo: 9999999997-15-014275 Size: 1 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-11-05 AccNo: 0001144204-15-063072 Size: 90 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2015-10-26 AccNo: 0001144204-15-060749 Size: 22 KB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2015-10-27 AccNo: 0001144204-15-060967 Size: 4 MB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2015-10-27 AccNo: 0001144204-15-060820 Size: 4 MB 网页链接
$Oasmia Pharmaceutical AB(OASM)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2015-10-23 AccNo: 0001019155-15-000353 Size: 88 KB 网页链接